argenx SE financials
Also U.S.-listed. argenx SE is also a foreign private issuer filing with the U.S. SEC. View its EDGAR financials: ARGX — ARGENX SE
argenx SE
Country: NL Reporting currency: USD Latest annual report: 2025-12-31
LEI:
7245009C5FZE6G9ODQ71 Financial statements
(USD, as reported — unscaled; 95 line items across 3 annual periods)
| Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income statement | |||
| Cost of sales | $450.7M | $227.3M | $117.8M |
| Other income | $96.7M | $66.2M | $77.8M |
| Operating expenses | $3.19B | $2.27B | $1.69B |
| Operating profit (EBIT) | $1.05B | -$21.7M | -$425.0M |
| Finance costs | $4.1M | $2.5M | $906.0K |
| Profit before tax | $1.28B | $85.2M | -$304.5M |
| Income tax expense | -$13.4M | -$747.9M | -$9.4M |
| Profit for the year | $1.29B | $833.0M | -$295.1M |
| — attributable to owners | $1.29B | $833.0M | -$295.1M |
| Total comprehensive income | $1.30B | $827.7M | -$294.7M |
| Per share | |||
| Basic EPS | $21.08 | $13.92 | $-5.16 |
| Diluted EPS | $19.57 | $12.78 | $-5.16 |
| Free cash flow / share | $10.28 | $-1.30 | $-7.37 |
| Cash flow statement | |||
| Cash generated from operations | $940.9M | -$90.2M | -$382.6M |
| Net cash from operating activities | $685.2M | -$82.7M | -$420.3M |
| Net cash from investing activities | $984.0M | -$717.6M | $308.2M |
| Purchase of PP&E (capex) | $6.2M | $1.8M | $812.0K |
| Purchase of intangibles | $105.5M | $66.5M | $43.0M |
| Net cash from financing activities | $233.0M | $279.8M | $1.34B |
| Lease liability payments | $4.1M | $7.6M | $3.8M |
| Net change in cash | $1.90B | -$520.6M | $1.22B |
| Balance sheet | |||
| Total assets | $8.68B | $6.20B | $4.54B |
| Non-current assets | $1.78B | $1.32B | $418.7M |
| Current assets | $6.90B | $4.88B | $4.12B |
| Inventories | $473.5M | $407.2M | $310.6M |
| Trade & other receivables | $1.65B | $904.5M | $496.7M |
| Cash & equivalents | $3.49B | $1.50B | $2.05B |
| Total equity | $7.32B | $5.50B | $4.10B |
| Non-current liabilities | $39.4M | $34.3M | $22.0M |
| Lease liabilities (non-current) | $36.3M | $32.5M | $15.4M |
| Current liabilities | $1.32B | $669.9M | $423.0M |
| Lease liabilities (current) | $10.8M | $6.5M | $4.6M |
| Trade & other payables | $1.27B | $650.0M | $414.0M |
| Deferred tax liabilities | $0 | $0 | $5.2M |
| Derived metrics | |||
| Free cash flow | $679.0M | -$84.5M | -$421.1M |
| Operating margin | 25.4% | -1.0% | -35.7% |
| Net margin | 31.1% | 38.1% | -24.8% |
| Return on equity | 17.6% | 15.2% | -7.2% |
| Cash conversion ratio | 0.53× | -0.10× | 1.42× |
| Capex coverage | 111.14× | -45.95× | -517.64× |
| Other reported items | |||
| Adjusted Weighted Average Shares | 66.0M | 65.2M | 57.2M |
| Adjustments For Amortisation Expense | $14.9M | $10.3M | $105.7M |
| Adjustments For Decrease Increase In Inventories | -$99.0M | -$96.0M | -$83.0M |
| Adjustments For Decrease Increase In Other Current Assets | -$5.7M | -$2.0M | -$943.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -$802.3M | -$423.1M | -$185.7M |
| Adjustments For Depreciation Expense | $13.2M | $7.2M | $5.6M |
| Adjustments For Gains Losses On Change In Fair Value of Financial Assets | $11.6M | $3.8M | $0 |
| Adjustments For Increase Decrease In Trade and Other Payables | $612.3M | $246.3M | $95.6M |
| Adjustments For Provisions | $1.2M | $432.0K | $573.0K |
| Adjustments For Sharebased Payments | $248.1M | $235.2M | $233.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -$12.4M | -$7.6M | -$4.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | $1.36B | $235.0M | -$73.7M |
| Comprehensive Income Attributable To Owners of Parent | $1.30B | $827.7M | -$294.7M |
| Current Prepaid Expenses | $328.5M | $187.9M | $134.1M |
| Current Tax Liabilities Current | $42.2M | $13.4M | $4.3M |
| Decrease Increase Through Tax On Sharebased Payment Transactions | -$38.8M | -$39.6M | -$2.3M |
| Deferred Tax Assets | $1.30B | $924.3M | $97.2M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $89.1M | -$28.3M | $23.5M |
| Equity and Liabilities | $8.68B | $6.20B | $4.54B |
| Finance Income | $163.1M | $157.5M | $107.4M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $65.8M | -$48.2M | $14.1M |
| Income Taxes Paid Refund Classified As Operating Activities | $254.9M | -$7.8M | $37.5M |
| Increase Decrease Through Exercise of Options | $279.0M | $319.5M | $158.3M |
| Increase Decrease Through Sharebased Payment Transactions | $249.3M | $235.9M | $234.2M |
| Intangible Assets Other Than Goodwill | $272.1M | $181.4M | $125.2M |
| Interest Paid Classified As Operating Activities | $900.0K | $392.0K | $211.0K |
| Interest Received Classified As Investing Activities | $162.7M | $111.6M | $92.8M |
| Investments In Joint Ventures Accounted For Using Equity Method | $3.4M | $9.3M | $9.9M |
| Issue of Equity | — | — | $1.20B |
| Issued Capital | $7.4M | $7.2M | $7.1M |
| Liabilities | $1.36B | $704.2M | $445.0M |
| Noncurrent Prepayments | $25.8M | $23.6M | $47.3M |
| Noncurrent Provisions For Employee Benefits | $3.1M | $1.8M | $1.4M |
| Other Adjustments For Noncash Items | $31.6M | -$277.0K | $2.1M |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | $6.5M | $7.0M | $13.0M |
| Other Comprehensive Income | $6.9M | -$5.4M | $348.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | $11.7M | -$4.7M | $2.3M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -$4.9M | -$648.0K | -$1.9M |
| Other Noncurrent Financial Assets | $52.0M | $42.4M | $39.7M |
| Payments For Share Issue Costs | $0 | $0 | $821.0K |
| Proceeds From Exercise of Options | $278.4M | $309.3M | $158.3M |
| Proceeds From Issuing Shares | $0 | $0 | $1.20B |
| Proceeds From Sales Or Maturity of Financial Assets Measured At Amortised Cost Classified As Investing Activities | $2.39B | $1.43B | $1.54B |
| Property Plant and Equipment Including Rightofuse Assets | $48.2M | $43.5M | $22.7M |
| Purchase of Financial Assets Measured At Amortised Cost Classified As Investing Activities | $1.45B | $2.18B | $1.27B |
| Research and Development Expense | $1.36B | $983.4M | $859.5M |
| Reserve of Exchange Differences On Translation | $138.6M | $126.8M | $131.5M |
| Retained Earnings | -$279.8M | -$1.57B | -$2.40B |
| Revenue and Operating Income | $4.25B | $2.25B | $1.27B |
| Revenue From Contracts With Customers | $4.15B | $2.19B | $1.19B |
| Selling General and Administrative Expense | $1.37B | $1.06B | $711.9M |
| Share Issue Related Cost | — | — | $821.0K |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | -$12.4M | -$7.6M | -$4.4M |
| Share Premium | $6.19B | $5.95B | $5.65B |
| Weighted Average Shares | 61.3M | 59.9M | 57.2M |
Methodology
Every line item above is a fact tagged in argenx SE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.